Donald J. Gogel is Chairman and Chief Executive Officer of Clayton, Dubilier & Rice, LLC, a private equity investment firm that he joined in 1989. CD&R currently manages more than $21 billion in capital with a portfolio of 22 companies that together have $85 billion in revenues and 200,000 employees around the world. The firm has been a leader for almost 40 years in integrating senior operative executives into its partnership. CD&R invests in a broad range of sectors in Europe and the United States—notably business consumer retail, health care and industrials. The firm has sponsored investments in companies like Brand Energy and Infrastructure Services, Diversey, Envision Healthcare, Hertz, Hussmann, PharMEDium, ServiceMaster, Spie, Solenis, and US Foods. Earlier in his career, Mr. Gogel was a partner at McKinsey & Company, as well as a founder of the merchant banking group at Kidder Peabody & Co., Inc.
Mr. Gogel is a member of the Business Council and the Trilateral Commission. He is Senior Vice Chairman of The Mount Sinai Medical System, Vice Chairman of the Cancer Research Institute, a Trustee of The Rhodes Trust and Chairman of the Board of The SeriousFun Children’s Network that serves 60,000 seriously-ill children around the world.
Mr. Gogel received a B.A. with highest honors from Harvard College in international relations and then studied politics on a Rhodes Scholarship at Oxford University’s Balliol College where he received an M. Phil. Mr. Gogel also received a J.D. from Harvard Law School. He played varsity lacrosse at both Harvard and Oxford.
Let's spread the word about Immunotherapy! Click to share this page with your community.